Does Hs-CRP elevation at presentation predict recurrence and disease activity in patients with acute pericarditis?
Hs-CRP is elevated in approximately 75% of acute pericarditis cases and can identify patients at higher risk of recurrence, suggesting its utility in monitoring disease activity and guiding therapy duration.
Hs-CRP is elevated at the initial presentation in ≈ 3 of 4 cases of acute pericarditis, identifies patients at higher risk of recurrence, and could be used to monitor disease activity and select appropriate therapy length.
Imazio et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: